FOXO6 and hepatocellular carcinoma: For example, Yu’s study showed that depletion of FOXO6 can inhibit glycolysis in HCC cells through the PI3K/AKT pathway and reduce the resistance of cells to paclitaxel (Yu et al., 2020).